Bimzelx 320 mg/2mL
bimekizumab · INJECTION, SOLUTION · UCB, Inc.
No Recall History
Plain English
Bimzelx is a injection, solution containing bimekizumab at 320 mg/2mL, taken subcutaneous. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- Bimzelx
- Generic Name
- bimekizumab
- NDC Code (Product)
50474-783- Manufacturer
- UCB, Inc.
- Strength
- 320 mg/2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761151
- Marketing Start
- 12/05/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Bimzelx used for?
Bimzelx contains bimekizumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Bimzelx a controlled substance?
Bimzelx is not classified as a controlled substance by the DEA.
What is the generic name for Bimzelx?
The generic name for Bimzelx is bimekizumab. There are no other listed brand versions of bimekizumab.
What is the NDC code for Bimzelx 320 mg/2mL?
The NDC (National Drug Code) for Bimzelx 320 mg/2mL is 50474-783, listed by UCB, Inc..
Other Bimzelx Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)